A study to evaluate the impact of a software to detect eye diseases (Google-ARDA) among people with type 2 diabetes in India.
- Conditions
- Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications
- Registration Number
- CTRI/2022/11/047093
- Lead Sponsor
- Google LLC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
With at least 3 years of diabetes duration from the date of diagnosis and
Resident of Delhi-NCR and
Willing/able to give consent to participate in the study
Participants who fall under any of the following criteria will be excluded:
Previous diagnosis of any Diabetic Retinopathy (DR)
Participants with any visual symptoms or conditions (e.g., loss of vision, blurry vision, persistent floaters), other than those corrected with glasses, contact lenses or other refractive corrections
Undergone any laser treatment of the retina in the past
Undergone any retinal surgeries
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of participants who had at least one visit at ophthalmology facility (for DR screening/follow up) within three months from the date of referralTimepoint: Three months from the date of referral
- Secondary Outcome Measures
Name Time Method Time taken to adhere with referrals to eye specialist (i.e., number of days it took for participants to see ophthalmologists from the date of referral) <br/ ><br>Measure the impact of enhanced standard care and ARDA on reducing the time between DR screening and start of ophthalmic management of a referable condition <br/ ><br>Proportion of referred participant, who had received any treatment from ophthalmology facility at three months from the date of referral <br/ ><br>Participant satisfaction with DR screening and referral (at three months) <br/ ><br>Timepoint: Three months from the date of referral